What is Anna-Brooke Harrison-Hall's NPI number?

Anna-Brooke Harrison-Hall's National Provider Identifier (NPI) is 1992444905, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Anna-Brooke Harrison-Hall's specialty?

Anna-Brooke Harrison-Hall is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).

Where is Anna-Brooke Harrison-Hall located?

Anna-Brooke Harrison-Hall's practice location on file with NPPES is 4300 W Main St Ste 102, Dothan, AL 36305-1306.

What is Anna-Brooke Harrison-Hall's phone number?

The practice phone number listed in the NPPES registry for Anna-Brooke Harrison-Hall is (334) 793-9564.

Does Anna-Brooke Harrison-Hall accept Medicare?

Anna-Brooke Harrison-Hall is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Anna-Brooke Harrison-Hall's NPI active?

Yes — Anna-Brooke Harrison-Hall's NPI (1992444905) is active in the NPPES registry as of the last update on 2022-05-31.

IndividualActiveAccepts Medicare

Anna-Brooke Harrison-Hall

NPI 1992444905 · Family Nurse Practitioner · Dothan, AL

Anna-Brooke Harrison-Hall is a Family Nurse Practitioner provider in Dothan, AL (NPI 1992444905).

Provider details

NPI number: 1992444905
Entity type: Individual
Primary specialty: Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
Sex: Female
Sole proprietor: No
License: 1-183066 (AL)

Practice location

4300 W Main St Ste 102

Dothan, AL 36305-1306

Phone: (334) 793-9564

Street-level locationGet directions

More AL providers

Mailing address

4300 W Main St Ste 102

Dothan, AL 36305-1306

Specialties & taxonomies

Family Nurse PractitionerPrimary363LF0000XLicense 1-183066 (AL)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(75/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
4 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,614 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,122	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	341	$70
Destruction of Precancer Skin Growth, 1 Growth17000	336	$40
Biopsy of Related Skin Growth, First Growth11102	253	$73
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	137	$85
Destruction of Precancer Skin Growth, 15 Or More Growths17004

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	262	87
Triamcinolone Acetonide	122	76
Mupirocin	101	66
Clobetasol Propionate	51	32
Clindamycin Phosphate	43	25
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	29	16
Doxycycline Hyclate	26	14
Metronidazole

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,407 across 43 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2022-05-31
Last updated: 2022-05-31
Certified: 2022-05-23

Frequently asked questions

What is Anna-Brooke Harrison-Hall's NPI number?: Anna-Brooke Harrison-Hall's National Provider Identifier (NPI) is 1992444905, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Anna-Brooke Harrison-Hall's specialty?: Anna-Brooke Harrison-Hall is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).
Where is Anna-Brooke Harrison-Hall located?: Anna-Brooke Harrison-Hall's practice location on file with NPPES is 4300 W Main St Ste 102, Dothan, AL 36305-1306.
What is Anna-Brooke Harrison-Hall's phone number?: The practice phone number listed in the NPPES registry for Anna-Brooke Harrison-Hall is (334) 793-9564.
Does Anna-Brooke Harrison-Hall accept Medicare?: Anna-Brooke Harrison-Hall is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Anna-Brooke Harrison-Hall's NPI active?: Yes — Anna-Brooke Harrison-Hall's NPI (1992444905) is active in the NPPES registry as of the last update on 2022-05-31.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,122	$5
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	341	$70
Destruction of Precancer Skin Growth, 1 Growth17000	336	$40
Biopsy of Related Skin Growth, First Growth11102	253	$73
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	137	$85
Destruction of Precancer Skin Growth, 15 Or More Growths17004

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	262	87
Triamcinolone Acetonide	122	76
Mupirocin	101	66
Clobetasol Propionate	51	32
Clindamycin Phosphate	43	25
Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone	29	16
Doxycycline Hyclate	26	14
Metronidazole

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,407 across 43 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments